Navigation Links
Enhanced Patient Positioning System Unveiled Further Refining Image Guided Radiation Therapy (IGRT)
Date:7/27/2012

CHICAGO, July 27, 2012 /PRNewswire/ -- Today, Brainlab officially unveils the new ExacTrac®1 6.0 Patient Positioning system, delivering key improvements for both frameless radiosurgery and radiotherapy treatments. This new system aims to further increase clinical value, deliver intuitive workflows and enable refined integration with peripheral systems. For more than two decades, Brainlab has been refining and revolutionizing precise patient setup for stereotactic treatments. Now, over 500 institutions have demonstrated their trust in the ExacTrac IGRT system with more than one million treatments performed.

"The overall precision of ExacTrac is deeply embedded in every facet of the system from its refined installation procedures to its ever-developing customer training to its vital network of experienced users," commented Stefan Vilsmeier, President and CEO at Brainlab. "Radiotherapy departments worldwide rely on ExacTrac because it instills user confidence by continuously and accurately targeting the intended volume, throughout the entire treatment. ExacTrac 6.0 is another Brainlab advancement dedicated to improving patient treatments and clinical results."

ExacTrac uses high-resolution stereoscopic X-Ray images to instantly detect and visualize internal structures and their location inside the body before and during treatment. A selective, intelligent image fusion algorithm allows the elimination of artifacts and ambiguities caused by objects not rigidly correlated to the target structure. Clinicians can then correct patient position in six dimensions of freedom in order to accurately target the treatment area.

Three major American facilities have already acquired the new system, including Memorial Sloan Kettering Cancer Center in New York City, UCSF Medical Center in San Francisco, and MD Anderson Cancer Center in Texas, which acquired two new systems and upgraded their existing installation. 

"We are proud to be one of the first hospitals in the US to implement the new ExacTrac platform," states Michael T. Gillin, Ph.D., Professor, Radiation Physics, UT MD Anderson Cancer Center. "The technological advancement can help us enhance our patient throughput and deliver state-of-the art cancer treatments. Only the fundamental architecture of ExacTrac allows us to instantaneously visualize internal structures during treatment, even at rotated couch and gantry angles."

ExacTrac 6.0 Features New Technology and Workflow Management:

  • New dual generator allows for simultaneous imaging, significantly reducing the setup time and further enhancing the utilization of intra-fraction snap verification
  • Remote control of the robotics module eliminates the need to enter the treatment room for rotational corrections
  • Cone beam CT integration2 allows for patient alignment in 6D based on volumetric cone beam images
  • Advanced integration with Record and Verify system enables users to export shifts and images in DICOM RT format and review offline

The new ExacTrac 6.0 platform will be showcased at this year's American Association of Physicists in Medicine (AAPM) annual meeting in Charlotte, NC.

About Brainlab 

Brainlab develops, manufactures and markets software-driven medical technology with the aim of optimizing patient treatments. Core products revolve around less-invasive image guided surgery technology, more accurate and effective radiation therapy, and integration through planning and collaboration systems that brings patient data and physicians together. www.brainlab.com

1 ® Registered trademark of Brainlab in Germany and the US

2 FDA clearance pending

Press enquiries to:

Jennifer Agnew
Account Supervisor
D +1 323 762 2417
M +1 323 240 4847
jennifer.agnew@porternovelli.com
porternovelli.com


'/>"/>
SOURCE Brainlab
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
2. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
3. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
4. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
5. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
6. Transitions Optical Brings Importance Of Healthy, Enhanced Vision Into Focus By Taking National Sightseeing City Tour To Chicago And Announcing The Citys Top 10 Sights To See
7. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
8. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Watching, Reading and Listening: A New Way to Interact with Patient Information
11. Phreesia identifies over 26% of patients who require additional autism evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016 The primary goal of ... adoption patterns on the usage of liquid biopsy. Key ... - Timeframe of liquid biopsy adoption amidst ... and Evs—by organization type - Sample inflow to conduct ... saliva, stool, serum, and so on. - Correlation analysis ...
(Date:2/11/2016)... Calif. , Feb. 11, 2016  Walgreens has ... across 39 states and Washington, D.C. ... a move that was commended by shareholder advocacy organization As ... at As You Sow. "Many people hold on to unneeded ... which can have tragic consequences." --> Conrad ...
(Date:2/11/2016)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... other birth tissues, human skin and bone, and patent-protected ... products and therapies, announced today that it will present ... in New York , NY.  Parker ... Senken , Chief Financial Officer and Chris Cashman ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... DDi , a Makro company, makes it ... expertise in eClinical Solutions. DDi has built its solution competency with a unique ... clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by ...
(Date:2/12/2016)... ... , ... Mystic Buddha Publishing House presents Valentine’s Day tips on different forms ... - Dr. Frederick Lenz. , According to Publisher Roger Cantu, “Blue Skies ... teaching and helping others. Valentine’s Day celebrates love in all its forms, and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to ... students from U.S. universities who will draw from Siemens’ deep knowledge of ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the ... , As Winston Churchill said, “Those who don’t learn from history are ... what to expect when they come knocking this year. But that takes time. , ...
(Date:2/12/2016)... Middletown, PA (PRWEB) , ... February 12, 2016 , ... ... year’s event will be held in Anaheim, CA at the Anaheim Convention Center. Almost ... they can see new therapy products in action, learn more about their chosen field ...
Breaking Medicine News(10 mins):